Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in:

Open Access 01-12-2023 | Breast Cancer | Research

Influence of alcohol consumption and alcohol metabolism variants on breast cancer risk among Black women: results from the AMBER consortium

Authors: Kristin L. Young, Andrew F. Olshan, Kathryn Lunetta, Mariaelisa Graff, Lindsay A. Williams, Song Yao, Gary R. Zirpoli, Melissa Troester, Julie R. Palmer

Published in: Breast Cancer Research | Issue 1/2023

Login to get access

Abstract

Background

Moderate to heavy alcohol consumption is associated with an increased risk of breast cancer. The etiologic role of genetic variation in genes involved in ethanol metabolism has not been established, with little information available among women of African ancestry.

Methods

Our analysis from the African American Breast Cancer Epidemiology and Risk (AMBER) Consortium included 2889 U.S. Black women who were current drinkers at the time of breast cancer diagnosis (N cases = 715) and had available genetic data for four ethanol metabolism genomic regions (ADH, ALDH, CYP2E1, and ALDH2). We used generalized estimating equations to calculate genetic effects, gene* alcohol consumption (≥ 7drinks/week vs. < 7/week) interactions, and joint main plus interaction effects of up to 23,247 variants in ethanol metabolism genomic regions on odds of breast cancer.

Results

Among current drinkers, 21% of cases and 14% of controls reported consuming ≥ 7 drinks per week. We identified statistically significant genetic effects for rs79865122-C in CYP2E1 with odds of ER- breast cancer and odds of triple negative breast cancer, as well as a significant joint effect with odds of ER- breast cancer (≥ 7drinks per week OR = 3.92, < 7 drinks per week OR = 0.24, pjoint = 3.74 × 10−6). In addition, there was a statistically significant interaction of rs3858704-A in ALDH2 with consumption of ≥ 7 drinks/week on odds of triple negative breast cancer (≥ 7drinks per week OR = 4.41, < 7 drinks per week OR = 0.57, pint = 8.97 × 10–5).

Conclusions

There is a paucity of information on the impact of genetic variation in alcohol metabolism genes on odds of breast cancer among Black women. Our analysis of variants in four genomic regions harboring ethanol metabolism genes in a large consortium of U.S. Black women identified significant associations between rs79865122-C in CYP2E1 and odds of ER- and triple negative breast cancer. Replication of these findings is warranted.
Appendix
Available only for authorised users
Literature
1.
Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001;286:2143–51.PubMedCrossRef
2.
Freudenheim JL. Alcohol’s effects on breast cancer in women. Alcohol Res Curr Rev. 2020;40:11.CrossRef
3.
Williams LA, Olshan AF, Hong C-C, Bandera EV, Rosenberg L, Cheng T-YD, et al. Alcohol intake and breast cancer risk in African American women from the AMBER consortium. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2017;26:787–94.CrossRef
4.
Humans IWG on the E of CR to. Alcohol consumption and ethyl carbamate. Iarc Monog Eval Carc. 2010;96:3–1383.
5.
Wright RM, McManaman JL, Repine JE. Alcohol-induced breast cancer: a proposed mechanism. Free Radic Bio Med. 1999;26:348–54.CrossRef
6.
Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol. 2007;30:5–13.
7.
Edenberg HJ, Xuei X, Chen H-J, Tian H, Wetherill LF, Dick DM, et al. Association of alcohol dehydrogenase genes with alcohol dependence: a comprehensive analysis. Hum Mol Genetics. 2006;15:1539–49.CrossRef
8.
9.
Stürmer T, Wang-Gohrke S, Arndt V, Boeing H, Kong X, Kreienberg R, et al. Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer. Br J Cancer. 2002;87:519–23.PubMedPubMedCentralCrossRef
10.
Freudenheim JL, Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, et al. Alcohol dehydrogenase 3 genotype modification of the associationof alcohol consumption with breast cancer risk. Cancer Causes Control. 1999;10:369–77.PubMedCrossRef
11.
Choi J-Y, Abel J, Neuhaus T, Ko Y, Harth V, Hamajima N, et al. Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics. 2003;13:67–72.PubMedCrossRef
12.
Park B, Kim J-H, Lee ES, Jung S-Y, Lee SY, Kang H-S, et al. Role of aldehyde dehydrogenases, alcohol dehydrogenase 1B genotype, alcohol consumption, and their combination in breast cancer in East-Asian women. Sci Rep-UK. 2020;10:6564.CrossRef
13.
McCarty CA, Reding DJ, Commins J, Williams C, Yeager M, Burmester JK, et al. Alcohol, genetics and risk of breast cancer in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Breast Cancer Res Treat. 2012;133:785–92.PubMedPubMedCentralCrossRef
14.
Hahn M, Simons CCJM, Weijenberg MP, van den Brandt PA. Alcohol drinking, ADH1B and ADH1C genotypes and the risk of postmenopausal breast cancer by hormone receptor status: the Netherlands cohort study on diet and cancer. Carcinogenesis. 2018;39:1342–51.PubMedCrossRef
15.
Hines LM, Hankinson SE, Smith-Warner SA, Spiegelman D, Kelsey KT, Colditz GA, et al. A prospective study of the effect of alcohol consumption and ADH3 genotype on plasma steroid hormone levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2000;9:1099–105.
16.
Lu Y, Zhu X, Zhang C, Jiang K, Huang C, Qin X. Role of CYP2E1 polymorphisms in breast cancer: a systematic review and meta-analysis. Cancer Cell Int. 2017;17:11.PubMedPubMedCentralCrossRef
17.
Wang L, Zhang Y, Ding D, He X, Zhu Z. Lack of association of ADH1C genotype with breast cancer susceptibility in Caucasian population: a pooled analysis of case–control studies. Breast. 2012;21:435–9.PubMedCrossRef
18.
Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005–12.PubMedCrossRef
19.
Shu X, Long J, Cai Q, Kweon S-S, Choi J-Y, Kubo M, et al. Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants. Nat Commun. 2020;11:1217.PubMedPubMedCentralCrossRef
20.
Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han Y-J, et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Hum Mol Genetics. 2016;25:4835–46.
21.
Adedokun B, Du Z, Gao G, Ahearn TU, Lunetta KL, Zirpoli G, et al. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nat Commun. 2021;12:4198.PubMedPubMedCentralCrossRef
22.
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genetics. 2020;52:572–81.PubMedCrossRef
23.
Park S-K, Yoo K-Y, Lee S-J, Kim S-U, Ahn S-H, Noh D-Y, et al. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics. 2000;10:301–9.PubMedCrossRef
24.
Kopp TI, Vogel U, Dragsted LO, Tjonneland A, Ravn-Haren G. Association between single nucleotide polymorphisms in the antioxidant genes CAT, GR and SOD1, erythrocyte enzyme activities, dietary and life style factors and breast cancer risk in a Danish, prospective cohort study. Oncotarget. 2017;8:62984–97.PubMedPubMedCentralCrossRef
25.
Dennis J, Krewski D, Côté F-S, Fafard E, Little J, Ghadirian P. Breast cancer risk in relation to alcohol consumption and BRCA gene mutations—a case-only study of gene-environment interaction. Breast J. 2011;17:477–84.PubMedCrossRef
26.
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, et al. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013;9:e1003284–314.PubMedPubMedCentralCrossRef
27.
Gonzales MC, Grayson J, Lie A, Yu CH, Shiao S-YPK. Gene-environment interactions and predictors of breast cancer in family-based multi-ethnic groups. Oncotarget. 2018;9:29019–35.PubMedPubMedCentralCrossRef
28.
Travis RC, Reeves GK, Green J, Bull D, Tipper SJ, Baker K, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the million women study. Lancet. 2010;375:2143–51.PubMedPubMedCentralCrossRef
29.
Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching PA, et al. Gene-environment interactions involving functional variants: results from the breast cancer association consortium. Int J Cancer. 2017;141:1830–40.PubMedPubMedCentralCrossRef
30.
Rudolph A, Milne RL, Truong T, Knight JA, Seibold P, Flesch-Janys D, et al. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer. 2015;136:E685–96.PubMedCrossRef
31.
Ugai T, Milne RL, Ito H, Aronson KJ, Bolla MK, Chan T, et al. The functional ALDH2 polymorphism is associated with breast cancer risk: a pooled analysis from the breast cancer association consortium. Mol Genetics Genom Med. 2019;7:e707.
32.
Wang X, Chen H, Kapoor PM, Su Y-R, Bolla MK, Dennis J, et al. A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women Limited role for GxE interactions in BrCa risk. Cancer Res Commun. 2022;2:211–9.PubMedPubMedCentralCrossRef
33.
Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, et al. The Carolina breast cancer study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51–60.PubMedCrossRef
34.
Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, et al. Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women. J Oncol. 2009;2009:871250.PubMedPubMedCentralCrossRef
35.
Bandera EV, Chandran U, Zirpoli G, McCann SE, Ciupak G, Ambrosone CB. Rethinking sources of representative controls for the conduct of case–control studies in minority populations. BMC Med Res Methodol. 2013;13:71.PubMedPubMedCentralCrossRef
36.
Rosenberg L, Adams-Campbell L, Palmer JR. The black women’s health study: a follow-up study for causes and preventions of illness. J Am Med Women’s Assoc. 1972;1995(50):56–8.
37.
Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–57.PubMedCrossRef
38.
Palmer JR, Ambrosone CB, Olshan AF. A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Cause Control. 2014;25:309–19.CrossRef
39.
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.PubMedPubMedCentralCrossRef
40.
Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44:955–9.PubMedPubMedCentralCrossRef
41.
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904–9.PubMedCrossRef
42.
43.
Haddad SA, Ruiz-Narvaez EA, Haiman CA, Sucheston-Campbell LE, Bensen JT, Zhu Q, et al. An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American women: the AMBER consortium. Carcinogenesis. 2016;37:870–7.PubMedPubMedCentralCrossRef
44.
Editorial Staff. Drinking patterns and their definitions. Alcohol Res Curr Rev. 2018;39:17–8.
45.
Lin D-Y, Tao R, Kalsbeek WD, Zeng D, Gonzalez F, Fernandez-Rhodes L, et al. Genetic association analysis under complex survey sampling: the hispanic community health study/study of Latinos. Am J Hum Genetics. 2014;95:675–88.CrossRef
46.
Jordahl KM, Shcherbina A, Kim AE, Su Y-R, Lin Y, Wang J, et al. Beyond GWAS of colorectal cancer: evidence of Interaction with alcohol consumption and putative causal variant for the 10q24.2 region. Cancer Epidemiol Biomarkers Prev. 2022;31:1077–89.PubMedPubMedCentralCrossRef
47.
Justice AE, Winkler TW, Feitosa MF, Graff M, Fisher VA, Young K, et al. Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits. Nat Commun. 2017;8:14977.PubMedPubMedCentralCrossRef
48.
Graff M, Scott RA, Justice AE, Young KL, Feitosa MF, Barata L, et al. Genome-wide physical activity interactions in adiposity—a meta-analysis of 200,452 adults. PLoS Genet. 2017;13:e1006528.PubMedPubMedCentralCrossRef
49.
Park J, Choi J-Y, Choi J, Chung S, Song N, Park SK, et al. Gene-environment interactions relevant to estrogen and risk of breast cancer: can gene-environment interactions be detected only among candidate SNPs from genome-wide association studies? Cancers. 2021;13:2370.PubMedPubMedCentralCrossRef
50.
Kraft P, Yen Y-C, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered. 2007;63:111–9.PubMedCrossRef
51.
52.
Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555–7.PubMedPubMedCentralCrossRef
53.
Xia Z, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, John EM, et al. Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the breast cancer health disparities study. Breast Cancer Res Treat. 2017;168:443–55.PubMedCrossRef
54.
Khedhaier A, Hassen E, Bouaouina N, Gabbouj S, Ahmed SB, Chouchane L. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer. 2008;8:109.PubMedPubMedCentralCrossRef
55.
Tanaka E, Terada M, Misawa S. Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther. 2000;25:165–75.PubMedCrossRef
56.
McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of HumanCYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharm. 1998;152:276–81.CrossRef
57.
Homann N, Stickel F, Konig IR et al. Cancer AJ J. Alcohol dehydrogenase 1C* 1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkers. Wiley Online Library; 2006
58.
Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Heal J Natl Inst Alcohol Abus Alcohol. 2007;30:5–13.
59.
Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature. 2019;570:514–8.PubMedPubMedCentralCrossRef
60.
Qin B, Babel RA, Plascak JJ, Lin Y, Stroup AM, Goldman N, et al. Neighborhood social environmental factors and breast cancer subtypes among black women. Cancer Epidemiol Prev Biomarkers. 2021;30:344–50.CrossRef
61.
Babatunde OA, Eberth JM, Felder T, Moran R, Truman S, Hebert JR, et al. Social determinants of racial disparities in breast cancer mortality among black and white women. J Racial Ethn Heal Disparities. 2019;8:147–56.CrossRef
62.
Plascak JJ, Beyer K, Xu X, Stroup AM, Jacob G, Llanos AAM. Association between residence in historically redlined districts indicative of structural racism and racial and ethnic disparities in breast cancer outcomes. JAMA Netw Open. 2022;5:e2220908.PubMedPubMedCentralCrossRef
63.
Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, et al. Mortgage lending bias and breast cancer survival among older women in the United States. J Clin Oncol. 2021;39:2749–57.PubMedPubMedCentralCrossRef
64.
Metadata
Title
Influence of alcohol consumption and alcohol metabolism variants on breast cancer risk among Black women: results from the AMBER consortium
Authors
Kristin L. Young
Andrew F. Olshan
Kathryn Lunetta
Mariaelisa Graff
Lindsay A. Williams
Song Yao
Gary R. Zirpoli
Melissa Troester
Julie R. Palmer
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2023
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-023-01660-1

Other articles of this Issue 1/2023

Breast Cancer Research 1/2023 Go to the issue

Research

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

Research

RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling

Research

Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer

Research

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer

Research

Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort

Research

Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low

2024 ESMO Congress

Add-on Ra223 could be a new first-line option in mCRPC

Adding radium-223 to first-line enzalutamide significantly improves the survival of patients with bone metastatic castration-resistant prostate cancer.

Read more

AI model can predict tumor mutations

No OS benefit of adding preoperative CRT in gastric cancer

T-DXd supported for breast cancer with brain metastases

» View more highlights on the ESMO 2024 hub page

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

Live event concluded

In this webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version
Image Credits